ADVANCED GASTROESOPHAGEAL JUNCTION CANCER

Clinical trials for ADVANCED GASTROESOPHAGEAL JUNCTION CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED GASTROESOPHAGEAL JUNCTION CANCER trials appear

Sign up with your email to follow new studies for ADVANCED GASTROESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug targets common cancer driver in first human trial

Disease control Recruiting now

This is an early-stage study testing a new drug called BGB-53038, which is designed to block a specific protein (KRAS) that drives the growth of many advanced solid tumors. The main goal is to find a safe dose and see how the body handles the drug, both when given alone and when …

Matched conditions: ADVANCED GASTROESOPHAGEAL JUNCTION CANCER

Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control

Last updated Apr 01, 2026 21:56 UTC

ADVANCED GASTROESOPHAGEAL JUNCTION CANCER

Get alerted when new ADVANCED GASTROESOPHAGEAL JUNCTION CANCER trials appear

New drug targets common cancer driver in first human trial